EXCLUSIVE OPTION AGREEMENT AMONG YANGLING SLOVAN PHARMACEUTICALS CO., LTD., YANGLING DONGKE MAIDISEN PHARMACEUTICALS CO., LTD., AND THE THIRTEEN PERSONS AS THE SHAREHOLDERS OF YANGLING DONGKE MAIDISEN PHARMACEUTICALS CO. Date: January 27, 2010 Xian, China

YANGLING SLOVAN PHARMACEUTICALS CO., LTD.

 

Address: Building 4 Incubator Park West Xinqiao Road, Yangling Demonstration Zone, Xi'an, Shaanxi Province, P.R.C.

 

Legal Representative: Lihong Zhang

 

Zhao Dongke, PRC citizen with ID Card number [610113195411180418]

Wei Jingkun, PRC citizen with ID Card number [610113195409250448]

Zhao Jine, PRC citizen with ID Card number [130403195701150961]

Yang Quanfu, PRC citizen with ID Card number [610104196508251612]

Zhao Wenyan, PRC citizen with ID Card number [610113198109240487]

Yang Xueli, PRC citizen with ID Card number [610104196911246186]

Li Gang, PRC citizen with ID Card number [612526731013001]

Zhang Guofeng, PRC citizen, ID Card number [610429197302174170]

Zhao Ruojing, PRC citizen with ID Card number [610404198009130547]

Zhao Yaolong, PRC citizen with ID Card number [610429198609243016]

Su Tong, PRC citizen with ID Card number [61012519761008196x]

Zhang Daokai, PRC citizen, ID Card number [330327196009227595]

Zhang Jiansheng, PRC citizen, ID Card number [130403195711170931]

 YANGLING DONGKE MAIDISEN PHARMACEUTICALS CO., LTD.

 

Address: No.8 of Xinqiao Road, Yangling High-tech of Agriculture Demonstration Region, Xi'an, Shaanxi Province, P.R.C.

 

Legal Representative: Dongke Zhao

 

 

Legal Representative:

1.

Party A is a wholly foreign-owned enterprise incorporated under the laws of the People’s Republic of China (the “PRC”);

2.

 

Party C is a limited liability company incorporated in Shaanxi and with business license issued by the Shaanxi  Municipal Administration for Industry and Commerce;

3 .

As of the date of this Agreement Party B are shareholders of YANGLING DONGKE MAIDISEN PHARMACEUTICALS CO., LTD. (hereinafter referred to as (“MAIDISEN SHAREHOLDERS”) and collectively legally hold all of the equity interest of YANGLING DONGKE MAIDISEN PHARMACEUTICALS CO., LTD. Under this Agreement, Party B, The Thirteen Persons  have acted collectively as one party to this Agreement;

1.

THE GRANT AND EXERCISE OF PURCHASE OPTION

2.

Price of Acquisition

3 .

REPRESENTATIONS AND WARRANTIES

3.1

Each party hereto represents to the other parties that: (1) it has all the necessary rights, powers and authorizations to enter into this Agreement and perform its duties and obligations hereunder; and (2) the execution or performance of this Agreement shall not violate any significant contract or agreement to which it is a party or by which it or its assets are bounded.

3.2

Party B hereto represents to Party A that: (1) they are legally registered shareholders of Party C and have paid Party C the full amount of their respective portions of Party C's registered capital required under the PRC laws; (2) except Share Pledge Agreement, Party B has not mortgaged or pledged his shares of Party C, nor has either of them granted any security interest or borrow against his shares of Party C in any form; and (3) Party B has not sold or will not sell to any third party its equity interests in Party C.

3.3

Party C hereto represents to Party A that: (1) it is a limited liability company duly registered and validly existing under the PRC law; and (2) its business operations are in compliance with applicable laws of the PRC in all material aspects.

4 .

COVENANTS

The Parties further agree as follows:

4.1

Before Party A has acquired all the equity/assets of Party C by exercising the purchase option provided hereunder, Party C shall not:

4.1.1

sell, assign, mortgage or otherwise dispose of, or create any encumbrance on, any of its assets, operations or any legal or beneficiary interests with respect to its revenues (unless such sale, assignment, mortgage, disposal or encumbrance is relating to its daily operation or has been disclosed to and agreed upon by Party A in writing);

4.1.2

enter into any transaction which may materially affect its assets, liability, operation,

shareholders’ equity or other legal rights (unless such transaction is relating to its

daily operation or has been disclosed to and agreed upon by Party A in writing); and

4.1.3

distribute any dividend to its shareholders in any manner.

4.2

Before Party A has acquired all the equity/assets of Party C by exercising the purchase option provided hereunder, Party B and/or Party C shall not individually or collectively:

4.2.1

supplement, alter or amend the articles of association of Party C in any manner to the

extent that such supplement, alteration or amendment may have a material effect on

Party C's assets, liability, operation, shareholders’ equity or other legal rights;

4.2.2

cause Party C to enter into any transaction to the extent such transaction may have a material effect on Party C's assets, liability, operation, shareholders’ equity or other legal rights (unless such transaction is relating to Party C's daily operation or has been disclosed to and agreed upon by Party A in writing); and

 

4.3

Party B shall entrust Party A to manage Party C in accordance with Entrusted Management Agreement.

 

5 .

ASSIGNMENT OF AGREEMENT

5.1

Party B and Party C shall not transfer their rights and obligations under this Agreement to any third party without the prior written consent of Party A.

 

5.2

Each of Party B and Party C hereby agrees that Party A shall have the right to transfer all of its rights and obligation under this Agreement to any third party whenever it desires. Any such transfer shall only be subject to a written notice sent to Party B and Party C by Party A, and no any further consent from Party B and Party C will be required.

 

6 .

CONFIDENTIALITY

The Parties acknowledge and confirm that any oral or written materials exchanged by the Parties in connection with this Agreement are confidential. The Parties shall maintain the secrecy and confidentiality of all such materials. Without the written approval by the other Parties, any Party shall not disclose to any third party any relevant materials, but the following circumstances shall be excluded:

 

a.

The materials is known by the public (except for any materials disclosed to the public by the Party who receives such materials) or the materials is already known by the disclosing Party or acquired by the disclosing Party from a third party lawfully in possession thereof with no obligation of confidentiality;

 

b.

The materials are required to be disclosed under the applicable laws or the rules or provisions of stock exchange; or

 

c.

The materials disclosed by each Party to its legal or financial consultant relate to the transaction contemplated under this Agreement, and such legal or financial consultant shall comply with the confidentiality set forth in this Section. The disclosure of the confidential materials by an employee of any Party shall be deemed disclosure of such materials by such Party, and such Party shall be liable for breaching the contract. This Article 6 shall survive this Agreement even if this Agreement is invalid, amended, revoked, terminated or unenforceable by any reason.

7 .

BREACH OF CONTRACT

 

Any violation of any provision hereof, any incomplete or mistaken performance of any obligation provided hereunder, any misrepresentation made hereunder, any material nondisclosure or omission of any material fact, or any failure to perform any covenants provided hereunder by any Party shall constitute a breach of this Agreement. The breaching Party shall be liable for any such breach pursuant to the applicable laws.

 

8 .

APPLICABLE LAW AND DISPUTE RESOLUTION

 

8.1

Applicable Law

The execution, validity, interpretation and performance of this Agreement and the disputes resolution under this Agreement shall be governed by the laws of PRC.

。

 

8.2

Dispute Resolution

The parties shall strive to settle any dispute arising from the interpretation or performance of this Agreement through friendly consultation. In case no settlement can be reached through consultation within thirty (30) days after such dispute is raised, each Party shall have the right to submit such matter to China International Economic and Trade Arbitration Commission (the “CIETAC”) in Beijing in accordance with its rules. The arbitration shall take place in Beijing. The arbitration award shall be final, conclusive and binding upon both parties.

9.

EFFECTIVENESS AND TERMINATION

9.1

This Agreement shall be effective upon the execution hereof by all Parties hereto and shall remain effective thereafter.

9.2

This Agreement may not be terminated without the unanimous consent of all the Parties except that Party A may, by giving a thirty (30) days prior notice to the other Parties hereto, terminate this Agreement.

1 0.

MISCELLANEOUS

10.1

Amendment, Modification and Supplement

Any amendment and supplement to this Agreement shall be made by the Parties in writing. The amendment  and supplement duly executed by each Party shall be deemed an integral part of this Agreement and shall have the same legal effect as this Agreement.

10.2

Entire Agreement

The Parties acknowledge that this Agreement constitutes the entire agreement of the Parties with respect to the subject matters therein and supersedes and replaces all prior or contemporaneous agreements and understandings in oral or written form

10.3

Severability

If any provision of this Agreement is adjudicated to be invalid or non-enforceable according to relevant PRC laws of the PRC, such a provision shall be deemed invalid only to the extent the PRC laws are applicable in China, and the validity, legality and enforceability of the other provisions hereof shall not be affected or impaired in any way. The Parties shall, through consultation based on the principal of fairness, replace such invalid, illegal or non-enforceable provision with valid provision so that any substituted provision may bring the similar economic effects as those intended by the invalid, illegal or non-enforceable provision.

10.4

Headings

The headings contained in this Agreement are for the convenience of reference only and shall not in any other way affect the interpretation, explanation or the meaning of the provisions of this Agreement.

10.6

Successor

This Agreement shall bind and benefit the successor or the transferee of each Party.

 

 

Legal Representative: Zhao Dongke